Andhra Pradesh, India

Aryasomayajula Ratnakar

This inventor holds 1 USPTO granted patent. Top assignee: Hetero Drugs Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aryasomayajula Ratnakar. Retrieved from https://idiyas.com/inventor/aryasomayajula-ratnakar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aryasomayajula Ratnakar: Innovator in Nucleoside Derivatives

Introduction

Aryasomayajula Ratnakar is a prominent inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel nucleoside derivatives. His work focuses on creating compounds that have potential applications in antiviral, anti-tumor, and immunomodulatory activities.

Latest Patents

Ratnakar holds a patent for nucleoside derivatives, which are described in his patent application. This application relates to novel nucleoside derivatives and intermediates that are useful in treating diseases, conditions, and disorders modulated by viral infections. The processes for preparing these compounds are also outlined in his patent.

Career Highlights

Ratnakar is associated with Hetero Drugs Limited, a leading pharmaceutical company. His role at the company has allowed him to work on innovative solutions that address critical health challenges. His expertise in the field has positioned him as a valuable asset to the organization.

Collaborations

Some of his notable coworkers include Bandi Parthasaradhi Reddy and Vedula Manohar Sharma. Their collaboration has contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Aryasomayajula Ratnakar's work in nucleoside derivatives showcases his commitment to innovation in the pharmaceutical industry. His contributions have the potential to impact the treatment of various diseases significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…